CD38 Deficiency Alleviates Diabetic Cardiomyopathy by Coordinately Inhibiting Pyroptosis and Apoptosis.
CD38 Deficiency Alleviates Diabetic Cardiomyopathy by Coordinately Inhibiting Pyroptosis and Apoptosis.
复制标题
DOI:
10.3390/ijms242116008
复制
发表时间:
2023-11-06
影响因子:
5.6
通讯作者:
Xin HB
中科院分区:
文献类型:
--
作者:
Wang LF;Li Q;Wen K;Zhao QH;Zhang YT;Zhao JL;Ding Q;Guan XH;Xiao YF;Deng KY;Xin HB
Diabetic cardiomyopathy is one of the diabetes mellitus-induced cardiovascular complications that can result in heart failure in severe cases, which is characterized by cardiomyocyte apoptosis, local inflammation, oxidative stress, and myocardial fibrosis. CD38, a main hydrolase of NAD+ in mammals, plays an important role in various cardiovascular diseases, according to our previous studies. However, the role of CD38 in diabetes-induced cardiomyopathy is still unknown. Here, we report that global deletion of the CD38 gene significantly prevented diabetic cardiomyopathy induced by high-fat diet plus streptozotocin (STZ) injection in CD38 knockout (CD38-KO) mice. We observed that CD38 expression was up-regulated, whereas the expression of Sirt3 was down-regulated in the hearts of diabetic mice. CD38 deficiency significantly promoted glucose metabolism and improved cardiac functions, exemplified by increased left ventricular ejection fraction and fractional shortening. In addition, we observed that CD38 deficiency markedly decreased diabetes or high glucose and palmitic acid (HG + PA)-induced pyroptosis and apoptosis in CD38 knockout hearts or cardiomyocytes, respectively. Furthermore, we found that the expression levels of Sirt3, mainly located in mitochondria, and its target gene FOXO3a were increased in CD38-deficient hearts and cardiomyocytes with CD38 knockdown under diabetic induction conditions. In conclusion, we demonstrated that CD38 deficiency protected mice from diabetes-induced diabetic cardiomyopathy by reducing pyroptosis and apoptosis via activating NAD+/Sirt3/FOXO3a signaling pathways.
登录
查看更多内容
影响因子:
20.1
作者:
Oka SI;Byun J;Huang CY;Imai N;Ralda G;Zhai P;Xu X;Kashyap S;Warren JS;Alan Maschek J;Tippetts TS;Tong M;Venkatesh S;Ikeda Y;Mizushima W;Kashihara T;Sadoshima J
通讯作者:
Sadoshima J
影响因子:
5.3
作者:
Guan XH;Hong X;Zhao N;Liu XH;Xiao YF;Chen TT;Deng LB;Wang XL;Wang JB;Ji GJ;Fu M;Deng KY;Xin HB
通讯作者:
Xin HB
DOI:
10.1161/circheartfailure.120.008170
发表时间:
2021-08
期刊:
Circulation. Heart failure
影响因子:
--
作者:
Chiao YA;Chakraborty AD;Light CM;Tian R;Sadoshima J;Shi X;Gu H;Lee CF
通讯作者:
Lee CF
影响因子:
13.8
作者:
Chini EN;Chini CCS;Espindola Netto JM;de Oliveira GC;van Schooten W
通讯作者:
van Schooten W
影响因子:
--
作者:
Guan XH;Liu XH;Hong X;Zhao N;Xiao YF;Wang LF;Tang L;Jiang K;Qian YS;Deng KY;Ji G;Fu M;Xin HB
通讯作者:
Xin HB